Skip to content

2028 at other companies

Labcorp Holdings logo
Labcorp HoldingsLH
Tenet Healthcare logo
Tenet HealthcareTHC
Veeva Systems logo
Veeva SystemsVEEV
Medline, Inc.
 logo
Medline, Inc. MDLN
BridgeBio Pharma logo
BridgeBio PharmaBBIO
Guardant Health logo
Guardant HealthGH

Other financials

Income statement

See full
Revenue$706.6M+26.5%
Operating income$141.5M+24.6%
Net income$123.9M+8.1%
EPS (diluted)$4.28+16.6%

Balance sheet

See full
Cash & equivalents$652.7M+47.9%
Total debt$146.1M-2.8%
Total equity$598.3M+0.8%
Total assets$2.1B+12.2%

Cash flow

See full
Operating cash flow$151.8M+20.6%
CapEx$6.8M-31.8%
Free cash flow$145.0M+25.1%

Valuation

See full
Market cap$13.14B+46.8%
Enterprise value$12.64B+45.9%
P/E28.6×+7.0×
P/S4.9×+0.8×

Profitability

See full
Operating margin21%-0.1pp
Net margin17.2%-2.1pp
FCF margin26.5%+1.5pp

Returns & leverage

See full
Return on equity77.3%+11.4pp
Debt / equity0.2×0.0×
Current ratio0.8×+0.1×

Where this comes from

Reported directly by Medpace Holdings, Inc. in its filing.

Tagged under the XBRL concept us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo.

The official record: Medpace Holdings, Inc.’s 10-Q, filed April 23, 2026, on SEC EDGAR. View the filing →

Ask your AI about Medpace Holdings, Inc.'s 2028.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Medpace Holdings, Inc.'s 2028?
Medpace Holdings, Inc. (MEDP) reported 2028 of $577K in Q1 2026.
How has Medpace Holdings, Inc.'s 2028 changed year-over-year?
Medpace Holdings, Inc.'s 2028 decreased by 0.0% year-over-year, from $577K to $577K.